Writing in the June edition of DIA's Global Forum magazine, Harbour BioMed's Fang Zhou, in conversation with Sanofi China's Irene Deng, looks at how…

2020 was a challenging year globally, but one in which the importance of the healthcare and life sciences sector was underlined like never before.…

2020 will certainly go down in history as a watershed year for the global community, as a new strain of coronavirus – later named SARS-CoV-19 –…

With the global coronavirus pandemic still ongoing and teleworking having become the new normal, pharma executives from across the world are giving us…

PharmaBoardroom caught up with Dr Jingsong Wang, chairman & CEO of Harbour BioMed to discuss the exciting clinical and commercial milestones of…

Harbour BioMed is a fast-growing global biotech company with facilities in Rotterdam, Boston and Shanghai. The company is laser-focused on developing…